• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

TAK Stock price predictions?


<







Hang in there.... Christophe announced a buy back last week. Plans are to manipulate....er....rather.... reacquire our own stock at its new discounted price. ESPPs are usually bad juju.
 




Similar threads

Replies
5
Views
2K
Takeda
anonymous
Replies
70
Views
7K
Takeda
Anonymous